|
|
Line 1: |
Line 1: |
| [[Image:2qfh.jpg|left|200px]] | | {{Seed}} |
| | [[Image:2qfh.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
Line 9: |
Line 10: |
| {{STRUCTURE_2qfh| PDB=2qfh | SCENE= }} | | {{STRUCTURE_2qfh| PDB=2qfh | SCENE= }} |
|
| |
|
| '''Solution Structure of the C-terminal SCR-16/20 fragment of Complement Factor H.'''
| | ===Solution Structure of the C-terminal SCR-16/20 fragment of Complement Factor H.=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| Factor H (FH) is a plasma glycoprotein that plays a central role in regulation of the alternative pathway of complement. It is composed of 20 short complement regulator (SCR) domains. The SCR-1/5 fragment is required for decay acceleration and cofactor activity, while the SCR-16/20 fragment possesses binding sites for complement C3d and heparin. X-ray scattering and analytical ultracentrifugation showed that SCR-1/5 was monomeric, while SCR-16/20 formed dimers. The Guinier radius of gyration R(G) of 4.3 nm for SCR-1/5 and those of 4.7 nm and about 7.8 nm for monomeric and dimeric SCR-16/20, respectively, showed that their structures are partially folded back and bent. The distance distribution function P(r) showed that SCR-1/5 has a maximum dimension of 15 nm while monomeric and dimeric SCR-16/20 are 17 nm and about 27 nm long, respectively. The sedimentation coefficient of 2.4 S for SCR-1/5 showed no concentration-dependence, while that for SCR-16/20 was 2.8 S for the monomer and 3.9 S for the dimer. Sedimentation equilibrium data showed that SCR-1/5 is monomeric while SCR-16/20 exhibited a weak monomer-dimer equilibrium with a dissociation constant of 16 microM. The constrained scattering and sedimentation modelling of SCR-1/5 and SCR-16/20 showed that partially folded-back and bent flexible SCR arrangements fitted both data sets better than extended linear arrangements, and that the dimer was best modelled in the SCR-16/20 model by an end-to-end association of two SCR-20 domains. The SCR-1/5 and SCR-16/20 models were conformationally similar to the previously determined partially folded-back structure for intact wild-type FH, hence suggesting a partial explanation of the intact FH structure. Comparison of the SCR-16/20 model with the crystal structure of C3b clarified reasons for the distribution of mutations leading to atypical haemolytic uraemic syndrome.
| | The line below this paragraph, {{ABSTRACT_PUBMED_18005991}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 18005991 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_18005991}} |
|
| |
|
| ==About this Structure== | | ==About this Structure== |
Line 42: |
Line 46: |
| [[Category: Sushi]] | | [[Category: Sushi]] |
| [[Category: X-ray scattering]] | | [[Category: X-ray scattering]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 14:52:29 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 02:37:36 2008'' |